Mounjaro News
Latest articles and news about Mounjaro on AXL Media.
Latest Articles
- Pharmaceutical Peak Body Slams "Broken" PBS System as Mounjaro Subsidy Stalls
Published: Apr 28, 2026
Section: Medical News
Medicines Australia has labeled the nation's drug subsidy process "broken" after negotiations to list the diabetes medication Mounjaro on the Pharmaceutical Benefits Scheme (PBS) c...
- Clinical Study Warns of Critically Low Protein Intake and Nutritional Risks for GLP-1 Drug Users
Published: Apr 10, 2026
Section: Medical News
A real-world analysis of adults using GLP-1 receptor agonists, such as semaglutide and tirzepatide, has identified a significant risk of nutritional deficiency due to drastically r...
- UK Drug Watchdog Backs Novo Nordisk's Wegovy for Heart Disease Prevention via NHS
Published: Apr 1, 2026
Section: Companies & Industry
The National Institute for Health and Care Excellence (NICE) has recommended Wegovy for reducing the risk of heart attacks and strokes in obese adults. This landmark decision allow...
- Cleveland Clinic Study Finds 45% of Patients Maintain Weight Loss One Year After Halting GLP-1 Medications
Published: Mar 14, 2026
Section: Science & Tech
A retrospective analysis of nearly 8,000 adults reveals that discontinuing semaglutide or tirzepatide does not necessarily trigger the drastic weight regain observed in previous cl...
- New research suggests glp 1 weight loss drugs may assist heart recovery by restoring microvascular blood flow
Published: Mar 5, 2026
Section: Medical News
A study from the University of Bristol and University College London indicates that medications like Ozempic and Mounjaro could prevent secondary heart damage after a heart attack....
- New Survey Reveals 1 in 8 U.S. Adults Have Used Ozempic or Similar GLP-1 Medications
Published: Mar 3, 2026
Section: Healthy Lifestyle
A landmark survey released by KFF (Kaiser Family Foundation) has revealed the staggering reach of GLP-1 receptor agonists in the United States. According to the data, approximately...